| CAT # | Khoom npe | Kev piav qhia |
| PIB 0004 | Ertugliflozin | Ertugliflozin, tseem hu ua PF-04971729, yog ib qho muaj zog thiab xaiv inhibitor ntawm sodium-dependent glucose cotransporter 2 thiab cov neeg sib tw kho mob rau kev kho mob ntawm hom 2 mob ntshav qab zib mellitus. |
| TIAB SA 0048 | Omarigliptin | Omarigliptin, tseem hu ua MK-3102, yog ib qho muaj zog thiab ua haujlwm ntev DPP-4 inhibitor rau kev kho mob ntshav qab zib hom 2 ib zaug ib lim piam. |
| TIAB SA 1089 | Retagliptin | Retagliptin, tseem hu ua SP-2086, yog DPP-4 inhibitor uas siv tau rau kev kho mob ntshav qab zib hom 2. |
| TIAB SA 0088 | Trelagliptin | Trelagliptin, tseem hu ua SYR-472, yog ib qho kev ua yeeb yam ntev dipeptidyl peptidase-4 (DPP-4) inhibitor uas tau tsim los ntawm Takeda rau kev kho mob ntshav qab zib hom 2 (T2D). |
| TIAB SA 2039 | Linagliptin | Linagliptin, tseem hu ua BI-1356, yog DPP-4 inhibitor tsim los ntawm Boehringer Ingelheim rau kev kho mob ntshav qab zib hom II. |
| TSI 0100 | Sitagliptin | Sitagliptin (INN; yav dhau los pom tias yog MK-0431 thiab muag hauv lub npe lag luam Januvia) yog ib qho tshuaj tiv thaiv kab mob hauv qhov ncauj (cov tshuaj tiv thaiv kab mob ntshav qab zib) ntawm dipeptidyl peptidase-4 (DPP-4) inhibitor class. |
| PAB 0854 | LX-4211 | LX-4211 yog lub zog muaj zog dual SGLT2 / 1 inhibitor; Antidiabetic agents. |
| TIAB SA 1553 | TX-2761 | LX2761 yog ib qho chaw ua yeeb yam SGLT1 inhibitor uas muaj zog heev hauv vitro thiab qeeb plab hnyuv nqus dej hauv vivo los txhim kho glycemic tswj. |
